Fei-Meng Zheng

2.2k citations

33 papers · 1.7k indexed · h-index 20

Co-authors: Quentin Liu Jie Xu Min Yan Zi-Jie Long Eric W.‐F. Lam Fei Peng Bai Cui Mei-Yi Lin
Topics: Microtubule and mitosis dynamics (10 papers)Epigenetics and DNA Methylation (5 papers)Acute Myeloid Leukemia Research (4 papers)
Cited by: Cancer Research Cell Biology Oncology
Journals: Nature Communications Blood PLoS ONE
Partner nations: China United Kingdom Hong Kong

In The Last Decade

Fei-Meng Zheng

32 papers receiving 1.7k citations

Peers

Countries citing papers authored by Fei-Meng Zheng

Since Specialization

Citations

This map shows the geographic impact of Fei-Meng Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei-Meng Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei-Meng Zheng more than expected).

Fields of papers citing papers by Fei-Meng Zheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei-Meng Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei-Meng Zheng. The network helps show where Fei-Meng Zheng may publish in the future.

Co-authorship network of co-authors of Fei-Meng Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Fei-Meng Zheng. A scholar is included among the top collaborators of Fei-Meng Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei-Meng Zheng. Fei-Meng Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PAX6 enhances Nanog expression by inhibiting NOTCH signaling to promote malignant properties in small cell lung cancer cells 2025 ·Heliyon ·Xiaofang Guo,Lingling Wang,Fei-Meng Zheng,(unknown)	0
2	NDR1 activates CD47 transcription by increasing protein stability and nuclear location of ASCL1 to enhance cancer stem cell properties and evasion of phagocytosis in small cell lung cancer 2022 ·Medical Oncology ·Lingling Wang,(unknown),(unknown),(unknown),Fei-Meng Zheng	3
3	CPSF4 promotes tumor-initiating phenotype by enhancing VEGF/NRP2/TAZ signaling in lung cancer 2022 ·Medical Oncology ·Yingqiu Song,Kai Sun,(unknown),Linli Shi,Tao Qin,(unknown),Wuguo Deng,Wangbing Chen,Fei-Meng Zheng,Guiling Li	5
4	NDR1 increases NOTCH1 signaling activity by impairing Fbw7 mediated NICD degradation to enhance breast cancer stem cell properties 2022 ·Molecular Medicine ·Lingling Wang,(unknown),(unknown),Fei-Meng Zheng	16
5	β-Asarone increases doxorubicin sensitivity by suppressing NF-κB signaling and abolishes doxorubicin-induced enrichment of stem-like population by destabilizing Bmi1 2019 ·Cancer Cell International ·Lina Lv,(unknown),(unknown),Hongwen Li,Shuyou Li,Fei-Meng Zheng	7
6	The prognostic landscape of interactive biological processes presents treatment responses in cancer 2019 ·EBioMedicine ·Bin He,Rui Gao,Dekang Lv,Yalu Wen,Luyao Song,Xi Wang,Suxia Lin,Qitao Huang,(unknown),Zifeng Wang,Min Yan,Fei-Meng Zheng,Eric W.‐F. Lam,Keith W. Kelley,Zhiguang Li,Quentin Liu	6
7	H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance 2017 ·Cell Death and Disease ·Fei Peng,Tingting Li,(unknown),(unknown),(unknown),(unknown),(unknown),Wenjun Fan,(unknown),Mei Li,Bai Cui,Fei-Meng Zheng,(unknown),Eric W.‐F. Lam,Bo Wang,Jie Xu,Quentin Liu	203
8	Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype 2016 ·Nature Communications ·Fei-Meng Zheng,Caifeng Yue,Guohui Li,Bin He,Wei Cheng,Xi Wang,Min Yan,Zi‐Jie Long,Wanshou Qiu,Zhongyu Yuan,Jie Xu,Bing Liu,Qian Shi,Eric W.‐F. Lam,Mien‐Chie Hung,Quentin Liu	146
9	SOX1 down-regulates β-catenin and reverses malignant phenotype in nasopharyngeal carcinoma 2014 ·Molecular Cancer ·Zhong Guan,Jialiang Zhang,Jing Wang,Hefei Wang,Fei-Meng Zheng,(unknown),Yaodong Xu,Min Yan,Bing Liu,Bai Cui,Ying Huang,Quentin Liu	44
10	Up-Regulation of P21 Inhibits TRAIL-Mediated Extrinsic Apoptosis, Contributing Resistance to SAHA in Acute Myeloid Leukemia Cells 2014 ·Cellular Physiology and Biochemistry ·Xing Wu,Na Yang,(unknown),Jie Xu,(unknown),Fei-Meng Zheng,Zi-Jie Long,(unknown),(unknown),(unknown),(unknown),Quentin Liu	27
11	Inhibition of mTOR Pathway Sensitizes Acute Myeloid Leukemia Cells to Aurora Inhibitors by Suppression of Glycolytic Metabolism 2013 ·Molecular Cancer Research ·(unknown),Zi-Jie Long,(unknown),Fei-Meng Zheng,(unknown),Min Yan,(unknown),(unknown),(unknown),Dong-Jun Lin,Quentin Liu	59
12	Concomitant Targeting of Multiple Key Transcription Factors Effectively Disrupts Cancer Stem Cells Enriched in Side Population of Human Pancreatic Cancer Cells 2013 ·PLoS ONE ·Xiyan Wang,Quentin Liu,Benxin Hou,Wei Zhang,Min Yan,Huimin Jia,Haijun Li,Yan Dong,Fei-Meng Zheng,Wei Ding,(unknown),Hai Wang	30
13	EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies 2011 ·Gut ·Muyan Cai,(unknown),Fei-Meng Zheng,(unknown),(unknown),Hui Rao,Yangchao Chen,Qi‐Nian Wu,(unknown),Xin‐Yuan Guan,Mei-Yi Lin,Yi‐Xin Zeng,H F Kung,Dan Xie	138
14	EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin 2011 ·Oncogene ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Yiji Liao,Fei-Meng Zheng,Wei‐Guo Zhu,Tsung‐Hao Liu,(unknown),Xin‐Yuan Guan,Mei-Yi Lin,Mu‐Sheng Zeng,Y-X Zeng,(unknown),Dan Xie	176
15	Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells 2011 ·Journal of Translational Medicine ·Jia Rao,(unknown),Fei-Meng Zheng,Zi-Jie Long,(unknown),Xing Wu,(unknown),(unknown),Quentin Liu	73
16	The Mitotic Kinase Aurora-A Induces Mammary Cell Migration and Breast Cancer Metastasis by Activating the Cofilin-F-actin Pathway 2010 ·Cancer Research ·Lihui Wang,Jin Xiang,Min Yan,Yan Zhang,Yan Zhao,(unknown),Jie Xu,Fei-Meng Zheng,Jinna Chen,Zhuang Kang,(unknown),Da Xing,Quentin Liu	107
17	Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cells 2010 ·Medical Oncology ·(unknown),Min Yan,Guifang Guo,Fang Wang,Hui-Juan Qiu,Fei-Meng Zheng,Yan Zhang,Qiang Liu,Xiao‐Feng Zhu,Liang-Ping Xia	43
18	Pluripotency-associated genes in human nasopharyngeal carcinoma CNE-2 cells are reactivated by a unique epigenetic sub-microenvironment 2010 ·BMC Cancer ·(unknown),(unknown),Zi-Jie Long,Zhong‐Min Dai,(unknown),Yi Liang,Fei-Meng Zheng,Yi‐Xin Zeng,Quentin Liu	18
19	Aurora-A down-regulates IkappaBα via Akt activation and interacts with insulin-like growth factor-1 induced phosphatidylinositol 3-kinase pathway for cancer cell survival 2009 ·Molecular Cancer ·(unknown),Min Yan,Zhong Guan,(unknown),Liang-Ping Xia,(unknown),(unknown),Zi-Jie Long,Yan Zhao,(unknown),Fei-Meng Zheng,Jie Xu,Dong-Jun Lin,Quentin Liu	50
20	ZM 447439 inhibition of aurora kinase induces Hep2 cancer cell apoptosis in three-dimensional culture 2008 ·Cell Cycle ·Zi-Jie Long,Jie Xu,Min Yan,Jian Gang Zhang,(unknown),Da-zhi Xu,(unknown),(unknown),Fei-Meng Zheng,(unknown),(unknown),Yi-Xin Zeng,Quentin Liu	28

About Fei-Meng Zheng

Fei-Meng Zheng is a scholar working on Cell Biology, Cancer Research and Oncology, having authored 33 papers that have together received 1.7k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (10 papers), Epigenetics and DNA Methylation (5 papers) and Acute Myeloid Leukemia Research (4 papers). The work is most often cited by research in Cancer Research (538 citations), Cell Biology (379 citations) and Oncology (484 citations). Fei-Meng Zheng has collaborated with scholars based in China, United Kingdom and Hong Kong. Frequent co-authors include Quentin Liu, Jie Xu, Min Yan, Zi-Jie Long, Eric W.‐F. Lam, Fei Peng, Bai Cui, Mei-Yi Lin, Xin‐Yuan Guan and Dan Xie. Their work appears in journals such as Nature Communications, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact